Albex Gold 200 mg/ml oral suspension for cattle

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

Albendazole

可用日期:

Chanelle Pharmaceuticals Manufacturing Limited

ATC代码:

QP52AC11

INN（国际名称）:

Albendazole

剂量:

200 milligram(s)/millilitre

药物剂型:

Oral suspension

处方类型:

POM: Prescription Only Medicine as defined in relevant national legislation

治疗领域:

albendazole

授权状态:

Authorised

授权日期:

2019-07-19

产品特点

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Albex Gold 200 mg/ml oral suspension for cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Albendazole
200.0 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE
COMPOSITION
IF THAT
INFORMATION IS ESSENTIAL
FOR PROPER
ADMINISTRATION OF THE VETERINARY MEDICINAL
PRODUC
t
_ _
Methyl Parahydroxybenzoate (E218)
2.0 mg
Propyl Parahydroxybenzoate
0.2 mg
Citric Acid Monohydrate
Sodium Citrate
Xanthan Gum
Povidone 90
Polysorbate 20
Propylene Glycol
Simethicone Emulsion
White to off white suspension.
3.
CLINICAL PARTICULARS
3.1
TARGET SPECIES
Cattle.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the treatment of benzimidazole susceptible mature and developing
immature forms of
gastrointestinal roundworms, lungworms, tapeworms and adult liver
fluke in cattle. The product
is also ovicidal against fluke and roundworm eggs.
ROUNDWORMS
:
_Ostertagia, _
_Chabertia_
_, _
_Haemonchus, Trichostrongylus, Nematodirus, _
_Oesophagostomum, Bunostomum, Cooperia _
and
_Strongyloides _
spp
_. _
It is usually effective against inhibited larvae of
_Cooperia _
and
_Ostertagia. _
LUNGWORMS
:
_Dictyocaulus_
_viviparus._
TAPEWORMS
:
_Moniezia _
spp
_. _
ADULT LIVER FLUKE
:
_Fasciola hepatica_
.
The product is ovicidal and will kill fluke and roundworm eggs.
3.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
3.4
SPECIAL WARNINGS
Cattle suffering from severe lung damage due to heavy lungworm
infection may continue to
cough for some weeks after treatment.
Care should be taken to avoid the following practices because they
increase the risk of
development of resistance and could ultimately result in ineffective
therapy:
-
Too frequent and repeated use of anthelmintics from the same class,
over an extended period
of time.
-
Underdosing, which may be due to underestimation of body weight,
misadministration of the
product, or lack of calibration of the dosing device (if